Collectively, ceftriaxone could inhibit translation via targeting DDX3X, and concomitant inhibition of MYCN overexpression by drug treatment resulted in a significant repression of translation in MYCN‐amplified tumor cells. The gene discussed is DDX3X; the disease is neoplasm.